Mentari Therapeutics

MTRI
18.1102.63% ( -0.490 )
Trading: Nov 16, 12:58:43 (EDT)

Profile

About

Mentari Therapeutics
Mentari Therapeutics
MTRI.US

Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company’s products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.

Profile

Company Name
Mentari Therapeutics, Inc.
Market
NasdaqCM
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management